Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer

Nature Medicine

Volumn 25, Issue 6, 2019, Pages 968-976

  Yachida, Shinichi ^a,b   Mizutani, Sayaka ^c   Shiroma, Hirotsugu ^c   Shiba, Satoshi ^b   Nakajima, Takeshi ^d   Sakamoto, Taku ^d   Watanabe, Hikaru ^c   Masuda, Keigo ^c   Nishimoto, Yuichiro ^c   Kubo, Masaru ^c   Hosoda, Fumie ^b   Rokutan, Hirofumi ^b   Matsumoto, Minori ^d   Takamaru, Hiroyuki ^d   Yamada, Masayoshi ^d   Matsuda, Takahisa ^d   Iwasaki, Motoki ^e   Yamaji, Taiki ^e   Yachida, Tatsuo ^f   Soga, Tomoyoshi ^g   Kurokawa, Ken ^h   Toyoda, Atsushi ^h   Ogura, Yoshitoshi ⁱ   Hayashi, Tetsuya ⁱ   Hatakeyama, Masanori ^j   Nakagama, Hitoshi ^e   Saito, Yutaka ^d   Fukuda, Shinji ^g,k,l,m   Shibata, Tatsuhiro ^b,n   Yamada, Takuji ^c,m   more..

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e NATIONAL CANCER CENTER   (Japan)

^f KAGAWA UNIVERSITY   (Japan)

^g KEIO UNIVERSITY   (Japan)

^h NATIONAL INSTITUTE OF GENETICS   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j UNIVERSITY OF TOKYO   (Japan)

^k KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

^l UNIVERSITY OF TSUKUBA   (Japan)

^m JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

ⁿ UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRANCHED CHAIN AMINO ACID; DEOXYCHOLIC ACID; PHENYLALANINE;

ACTINOMYCES ODONTOLYTICUS; ADENOMA; ATOPOBIUM PARVULUM; CARCINOGENESIS; CARCINOMA; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; FUSOBACTERIUM NUCLEATUM; HUMAN; INTESTINE FLORA; INTRAMUCOSAL CARCINOMA; LETTER; MAJOR CLINICAL STUDY; METABOLOMICS; METAGENOMICS; PHENOTYPE; POLYPOID ADENOMA; PRIORITY JOURNAL; ADULT; AGED; CANCER STAGING; CASE CONTROL STUDY; COLORECTAL TUMOR; DISEASE EXACERBATION; FEMALE; GENETICS; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; METABOLOMICS; METAGENOMICS; MIDDLE AGED; NEOPLASM STAGING; YOUNG ADULT;

EID: 85067007334     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/s41591-019-0458-7     Document Type: Article

References (60)

1. Brenner, H., Kloor, M. & Pox, C. P. Colorectal cancer. Lancet 383, 1490–1502 (2014).
2. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
3. Jones, S. et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl Acad. Sci. USA 105, 4283–4288 (2008).
4. Ashktorab, H., Kupfer, S. S., Brim, H. & Carethers, J. M. Racial disparity in gastrointestinal cancer risk. Gastroenterology 153, 910–923 (2017).
5. Zeller, G. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 10, 766 (2014).
6. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299–306 (2012).
7. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012).
8. Yang, Y. et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-like receptor 4 signaling to nuclear factor-kB, and up-regulating expression of microRNA-21. Gastroenterology 152, 851–866 (2017).
9. Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661–672 (2014).
10. Hirayama, A. et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918–4925 (2009).
11. Liao, M. et al. Comparative analyses of fecal microbiota in Chinese isolated Yao population, minority Zhuang and rural Han by 16sRNA sequencing. Sci. Rep. 8, 1142 (2018).
12. Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
13. Ding, T. & Schloss, P. D. Dynamics and associations of microbial community types across the human body. Nature 509, 357–360 (2014).
14. Wong, J. M., de Souza, R., Kendall, C. W., Emam, A. & Jenkins, D. J. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235–243 (2006).
15. Emiola, A. & Oh, J. High throughput in situ metagenomic measurement of bacterial replication at ultra-low sequencing coverage. Nat. Commun. 9, 4956 (2018).
16. Brestoff, J. R. & Artis, D. Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 14, 676–684 (2013).
17. Zarling, E. J. & Ruchim, M. A. Protein origin of the volatile fatty acids isobutyrate and isovalerate in human stool. J. Lab. Clin. Med. 109, 566–570 (1987).
18. −/− mice. Nature 487, 104–108 (2012).
19. Mottawea, W. et al. Altered intestinal microbiota–host mitochondria crosstalk in new onset Crohn’s disease. Nat. Commun. 7, 13419 (2016).
20. Xu, H. et al. Isoleucine biosynthesis in Leptospira interrogans serotype lai strain 56601 proceeds via a threonine-independent pathway. J. Bacteriol. 186, 5400–5409 (2004).
21. Bui, T. P. et al. Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal. Nat. Commun. 6, 10062 (2015).
22. Prieto, M. A., Díaz, E. & García, J. L. Molecular characterization of the 4-hydroxyphenylacetate catabolic pathway of Escherichia coli W: engineering a mobile aromatic degradative cluster. J. Bacteriol. 178, 111–120 (1996).
23. Teufel, R. et al. Bacterial phenylalanine and phenylacetate catabolic pathway revealed. Proc. Natl Acad. Sci. USA 107, 14390–14395 (2010).
24. Russell, W. R. et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 93, 1062–1072 (2011).
25. Russell, W. R. et al. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol. Nutr. Food Res. 57, 523–535 (2013).
26. Windey, K., De Preter, V. & Verbeke, K. Relevance of protein fermentation to gut health. Mol. Nutr. Food Res. 56, 184–196 (2012).
27. Attene-Ramos, M. S., Wagner, E. D., Plewa, M. J. & Gaskins, H. R. Evidence that hydrogen sulfide is a genotoxic agent. Mol. Cancer Res. 4, 9–14 (2006).
28. Loubinoux, J., Bisson-Boutelliez, C., Miller, N. & Le Faou, A. E. Isolation of the provisionally named Desulfovibrio fairfieldensis from human periodontal pockets. Oral Microbiol. Immunol. 17, 321–323 (2002).
29. Feng, Q. et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat. Commun. 6, 6528 (2015).
30. Yu, J. et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66, 70–78 (2017).
31. Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443–1448 (2017).
32. Carbonero, F., Benefiel, A. C., Alizadeh-Ghamsari, A. H. & Gaskins, H. R. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front. Physiol. 3, 448 (2012).
33. Könönen, E. & Wade, W. G. Actinomyces and related organisms in human infections. Clin. Microbiol. Rev. 28, 419–442 (2015).
34. Kasai, C. et al. Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: terminal restriction fragment length polymorphism and next-generation sequencing analyses. Oncol. Rep. 35, 325–333 (2016).
35. Bernstein, H., Bernstein, C., Payne, C. M. & Dvorak, K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J. Gastroenterol. 15, 3329–3340 (2009).
36. Suzuki, K. & Bruce, W. R. Increase by deoxycholic acid of the colonic nuclear damage induced by known carcinogens in C57BL/6J mice. J. Natl Cancer Inst. 76, 1129–1132 (1986).
37. Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507–511 (2017).
38. Tahara, T. et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74, 1311–1318 (2014).
39. Ito, M. et al. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int J. Cancer 137, 1258–1268 (2015).
40. Mima, K. et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 65, 1973–1980 (2016).
41. Nishimoto, Y. et al. High stability of faecal microbiome composition in guanidine thiocyanate solution at room temperature and robustness during colonoscopy. Gut 65, 1574–1575 (2016).
42. Tsugane, S. & Sawada, N. The JPHC study: design and some findings on the typical Japanese diet. Jpn J. Clin. Oncol. 44, 777–782 (2014).
43. Furet, J. P. et al. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol. Ecol. 68, 351–362 (2009).
44. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
45. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10 (2011).
46. Mori, H., Maruyama, T., Yano, M., Yamada, T. & Kurokawa, K. VITCOMIC2: visualization tool for the phylogenetic composition of microbial communities based on 16S rRNA gene amplicons and metagenomic shotgun sequencing. BMC Syst. Biol. 12, 30 (2018).
47. Camacho, C. et al. BLAST+: architecture and applications. BMC Bioinformatics 10, 421 (2009).
48. Yarza, P. et al. Update of the All-Species Living Tree Project based on 16S and 23S rRNA sequence analyses. Syst. Appl. Microbiol. 33, 291–299 (2010).
49. Yarza, P. et al. Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences. Nat. Rev. Microbiol. 12, 635–645 (2014).
50. Sunagawa, S. et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat. Methods 10, 1196–1199 (2013).
51. Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902–903 (2015).
52. Holmes, I., Harris, K. & Quince, C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS ONE 7, e30126 (2012).
53. Asnicar, F., Weingart, G., Tickle, T. L., Huttenhower, C. & Segata, N. Compact graphical representation of phylogenetic data and metadata with GraPhlAn. PeerJ 3, e1029 (2015).
54. Peng, Y., Leung, H. C., Yiu, S. M. & Chin, F. Y. IDBA-UD: a de novo assembler for single-cell and metagenomic sequencing data with highly uneven depth. Bioinformatics 28, 1420–1428 (2012).
55. Besemer, J. & Borodovsky, M. Heuristic approach to deriving models for gene finding. Nucleic Acids Res. 27, 3911–3920 (1999).
56. Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27–30 (2000).
57. Soga, T. et al. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J. Proteome Res. 2, 488–494 (2003).
58. Mishima, E. et al. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int. 92, 634–645 (2017).
59. Tibshirani, R. Regression shrinkage and selection via the LASSO. J. R. Stat. Soc. B 58, 267–288 (1996).
60. Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).